This program is intended for cardiologists, primary care physicians, endocrinologists, nurse practitioners (NPs), physician assistants/physician associates (PAs), and other HCPs who manage patients with T2D with risk factors or established CV disease.
The goal of this program is to improve the knowledge, competence, and performance of learners in effort to optimize treatment for patients with type 2 diabetes (T2D) at high risk of cardiovascular events.
Upon completion of this activity, participants should be able to:
Evaluate the latest CV outcomes data and guideline recommendations for GLP-1 RA therapies in the management of T2D
Compare the clinical profiles of GLP-1 RA–based therapies for the management of T2D
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:
Darren K. McGuire, MD, MHSc, FACC
Distinguished Teaching Professor of Medicine
Jere H. Mitchell, MD Distinguished Chair in Cardiovascular Science
Division of Cardiology, Department of Medicine
University of Texas Southwestern Medical Center
Darren K. McGuire, MD, MHSc, FACC: consultant/advisor/speaker: Afimmune, Boehringer Ingelheim, GlaxoSmithKline, Lilly, Merck; researcher: Afimmune, AstraZeneca, Esperion, Lilly, Merck, Novo Nordisk, Sanofi.
Anne Peters, MD
USC Clinical Diabetes Programs
Professor of Clinical Medicine
Keck School of Medicine of USC
University of Southern California
Los Angeles, California
Anne Peters, MD: consultant/advisor/speaker: Abbott Diabetes Care, Lilly, Vertex, Zealand; researcher: Abbott Diabetes Care, Insulet.
Richard E. Pratley, MD
Samuel E. Crockett Chair in Diabetes Research
AdventHealth Diabetes Institute
Senior Investigator and Diabetes Program Lead
AdventHealth Translational Research Institute
Adjunct Professor of Medicine
Johns Hopkins University School of Medicine
Richard E. Pratley, MD: researcher (paid to institution): Dompe, Novo Nordisk; consultant/speaker (paid to institution): Bayer AG, Endogenex, Gasherbrum Bio, Hengrui, Intas Pharmaceuticals, Lilly, Merck, Novo Nordisk, Pfizer, Rivus Pharmaceutical, Sun Pharmaceutical Industries.
Payal Kohli, MD, FACC
Associate Clinical Professor of Medicine
Department of Medicine
University of Colorado Anschutz
Founder and Medical Director
Department of Cardiology
Cherry Creek Heart
Payal Kohli, MD, FACC: consultant/advisor/speaker: Agepha Pharma, Amarin, Amgen, AstraZeneca, Boston Scientific, Esperion, Merck, Zoll.
The planners and content peer reviewers from Clinical Care Options, LLC do not have any relevant financial relationships to disclose, except Lucia M. Novak, MSN, ANP-BC, BC-ADM and Amy Butts, PA-C as noted below:
Lucia M. Novak, MSN, ANP-BC, BC-ADM: consultant/advisor/speaker: Abbott Diabetes Care, Ascencia, Boehringer Ingelheim, Boehringer Ingelheim-Lilly Alliance, Medtronic, Novo Nordisk.
Amy Butts, PA-C: consultant/advisor/speaker: Abbott, Bayer, Novo Nordisk, Sanofi.
Participation in this self-study activity should be completed in approximately 0.5 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from November 10, 2023, through November 09, 2024:
You must receive a test score of 65 or better and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.
This program has been made available online.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 0.5 contact hours.
Physician Associate Continuing Medical Education
Clinical Care Options has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credit. Approval is valid until November 09, 2024. PAs should only claim credit commensurate with the extent of their participation.
American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.
By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).